Introduction
Parkinson disease (PD) is a common, neurodegenerative disorder principally affecting the degeneration of nigral dopaminergic neurons. The pathogenic mechanisms are unknown but valuable insight has been gained from identifying gene mutations causative for familial forms of PD (1) . Loss-of-function mutations in PINK1 and parkin are the major cause of autosomal recessive, early onset PD. PINK1 encodes a mitochondria targeted kinase (2) while parkin encodes an E3 ubiquitin ligase (3); a class of enzymes which conjugate ubiquitin to target substrates. This modification is usually considered in the context of substrate degradation by the proteasome, but ubiquitination also serves many other cellular functions.
Consequently, much emphasis has been put on elucidating a link between Parkin dysfunction and protein aggregation. Despite the identification of numerous putative Parkin substrates, an unequivocal causative link between substrate aggregation and pathogenesis remains debatable.
There is strong evidence, however, that supports an important role for Parkin in regulating mitochondrial homeostasis (4) . Studies have revealed a conserved function of Parkin acting downstream of PINK1 to protect mitochondrial integrity and prevent oxidative stress-induced apoptosis (5) (6) (7) (8) . Recently, we and others have reported that Drosophila parkin and PINK1 genetically interact with components of the mitochondrial fission and fusion machinery (9) (10) (11) (12) , suggesting that loss of PINK1/parkin function may lead to excess mitochondrial fusion. Consistent with this, mitochondrial elongation has been reported in cells derived from PD patients with parkin mutations (13) . However, the effects of parkin or PINK1 deficiency in mammalian cells remain unresolved since additional reports describe inconsistent phenotypes in PINK1 and parkin deficient cells (6, (14) (15) (16) (17) . The reasons for this discrepancy are unclear but warrant further clarification.
Important insight into the mechanism by which Parkin regulates mitochondrial homeostasis has revealed that upon mitochondrial depolarization Parkin translocates from the cytoplasm to accumulate on a subset of mitochondria, and promotes their degradation by autophagy (18). It has also been proposed that regulated mitochondrial fission/fusion helps sort out damaged mitochondria for degradation (19) (20) (21) . These findings raise the possibility that Parkin receives some signal identifying dysfunctional or damaged mitochondria, translocates and interacts with an unknown factor, to effect mitochondrial fission and/or fusion and promote mitophagy (22).
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Here we show that PINK1 is required for the recruitment of Parkin to damaged mitochondria and subsequent mitophagy, consistent with recent reports (23-25). Furthermore, we show that PINK1 and Parkin promote the ubiquitination of the pro-fusion factor Mfn. These findings suggest Mfn ubiquitination may provide a mechanism by which terminally damaged mitochondria are recognized for degradation by autophagy.
Results

PINK1 and Parkin knockdown causes mitochondrial elongation
Our previous genetic interaction studies in vivo, using both loss-and gain-of-function assays, indicate that Drosophila PINK1 and Parkin act to promote fission and/or inhibit fusion of mitochondria. To extend this study we quantified mitochondrial morphology upon loss-or gain-of-function of parkin and PINK1, alongside key regulators of mitochondrial morphology, in Drosophila S2R+ cells.
RNA interference (RNAi) can be robustly achieved in Drosophila cells by incubation of long double stranded RNA molecules complementary to the target gene (26). We performed targeted RNAi against PINK1, parkin and the Drosophila homologs of Drp1, Fis1, Opa1, and Mfn1/2 (here called Mfn). RNAi of these targets typically caused ~90% knockdown of the endogenous message after 3 days (Fig.   S1 ). We found that sample fixation grossly altered the mitochondrial morphology (Fig. S2A) , so for this study cells were imaged live using the selective mitochondrial dye rhodamine 123 (Fig. 1A,C) . As expected we found that knockdown of the profission genes Drp1 and Fis1 resulted in elongated mitochondria whereas knockdown of pro-fusion genes Opa1 and Mfn (also known as Marf) resulted in fragmented mitochondria. We found that knockdown of PINK1 or parkin caused a significant elongation of mitochondrial length. Elongated mitochondria were also seen when transfected mitoGFP was used to label mitochondria (Fig. S2B) . Conversely, 5 overexpression of Opa1 and Mfn caused a hyper-fused network while overexpression of Drp1 and Fis1 caused fragmentation (Fig. 1B,D) . Overexpression of parkin also caused fragmentation, however, the effect of PINK1 was not significant, suggesting PINK1 may not be limiting or may need to be activated itself to ectopically promote fragmentation.
The relative levels of key mitochondrial morphology factor transcripts were unchanged by parkin or PINK1 knockdown (Fig. S3A) , indicating the morphology changes do not occur from a transcriptional response altering the abundance of fission of fusion genes. Also, in contrast to a previous report (8) , we find Parkin protein levels are not changed in a PINK1 mutant (Fig. S3B ). Together these observations are consistent with the PINK1/Parkin pathway modulating the action of mitochondrial fission/fusion proteins to alter morphology.
PINK1 is required for Parkin translocation and Parkin-mediated mitophagy.
The recent study by Narendra et al. revealed an important insight into the function of Parkin, reporting it translocates to dysfunctional mitochondria and promotes mitophagy (18). We sought to determine whether this was a conserved function. In wild type Drosophila cells Parkin-GFP typically showed a diffuse localization throughout the cytoplasm with occasional accumulations at mitochondria ( Fig. 2A, and Fig. S4 ). Upon treatment with the mitochondrial uncoupling agent carbonyl cyanide m-chlorophenylhydrazone (CCCP) or the oxidative stressor paraquat a large proportion of cells showed Parkin-GFP accumulated at or near mitochondria ( Fig. 2A, and Fig. S5 ), while overall Parkin-GFP abundance remained constant (Fig. S3C) .
Prolonged exposure to CCCP also led to the autophagy dependent, but proteasome independent, loss of mitochondria (Fig. 2B, and Fig. S6 ). Consistent with previous reports Parkin was also required for CCCP-induced mitophagy in Drosophila cells (Fig. 2B ).
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To extend this observation we addressed whether PINK1, which acts upstream of Parkin, may affect the recruitment of Parkin to mitochondria and their autophagic degradation. Following PINK1 RNAi knockdown, CCCP or paraquat induced Parkin-GFP recruitment to mitochondria was prevented (Fig. 2C,D) . In addition, loss of PINK1 also abrogated mitophagy (Fig. 2B) . These data are consistent with PINK1 acting upstream to promote Parkin recruitment to dysfunctional mitochondria which in turn promotes their degradation. (Fig. 3A, white arrow) . Opa1 was present in a small amount of the full length form but predominantly in the processed form (Fig. 3A , white arrowhead), as previously reported (27). However, Mfn was detected as a number of high molecular weight isoforms (asterisks) in addition to the expected full length form (Fig. 3A, black arrowhead). The smallest Mfn isoform at ~91 kDa is consistent with the predicted size of the full length, unmodified form of Drosophila Mfn.
To assess whether these isoforms are ubiquitin modified, we performed coimmunoprecipitation experiments against HA-Ub. Immunoprecipitates of Flag-tagged To gain further evidence that Mfn ubiquitination may be mediated by Parkin we tested whether they may physically interact. Immunoprecipitation assays revealed that upon co-expression Parkin-GFP is detected in precipitates of Mfn-Flag (Fig. 3C ). Together these data strongly support that Parkin mediates the ubiquitination of Mfn.
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We sought to extend this observation in vivo. Using antibodies against Drosophila Mfn we could detect full length Mfn and high molecular weight Mfn-Ub (Fig. 3D) , consistent with that seen in vitro. These bands were absent upon Mfn RNAi knockdown in vivo (Fig. 3D) indicating the specificity of the antiserum.
Consistent with our in vitro results, Mfn-Ub was greatly reduced in a parkin mutant background (Fig. 3D) .
We have shown that PINK1 is required for Parkin recruitment to mitochondria, however, previous genetic experiments in vivo have shown that overexpression of parkin can compensate for loss of PINK1. Therefore, we addressed whether overexpressing parkin may restore Mfn ubiquitination in the absence of PINK1. In PINK1 RNAi knockdown cells only unmodified Mfn was seen (Fig. 4A) , however, when Parkin was overexpressed in PINK1 RNAi cells, the Mfn-Ub isoforms were again detected (Fig. 4A) . Conversely, if PINK1 was overexpressed in parkin RNAi cells Mfn-Ub isoforms were not restored ( While further work will be required to elucidate these mechanisms, this provides a molecular basis for the genetic hierarchy in which PINK1 acts upstream of Parkin (5-8).
In order to understand the role of Parkin translocation we took a candidate approach to identify putative substrates. Since the function of Parkin and PINK1, has been linked with mitochondrial dynamics we surveyed key components of the mitochondrial fission and fusion machinery for ubiquitin modification. We found that Mfn, which localizes to the outer surface of mitochondria, is ubiquitinated in a PINK1/Parkin dependent manner and accumulates upon loss of PINK1 or parkin.
Interestingly, the ubiquitinated isoforms do not show a typical ubiquitination 'ladder' but instead appear to reflect a pattern of one and three or four ubiquitin adducts.
While it remains to be shown that Parkin directly mediates this ubiquitination, there is evidence that Parkin can mediate mono-ubiquitination (33-37), K27 (23) and K63
linkages (38, 39) . These modes of ubiquitination are not typically linked to proteasome degradation, and there is growing speculation that important pathogenic functions of Parkin may be proteasome-independent (reviewed in (40) 
Materials and Methods
Cell culture and transfection S2R+ cells were cultured in Schneider's medium (Invitrogen) supplemented with 5% fetal calf serum (Sigma) and 1% penicillin-streptomycin (Invitrogen-Gibco). Cells were transfected using Effectene reagent (Qiagen) following manufacturer's instructions and collected after 24-48hrs. 500µM copper sulfate solution was added to the cells to induce plasmid expression when required. Where indicated cells were treated with 10µM CCCP for 2 hrs or 10mM paraquat for 6 hrs.
RNAi treatment and quantification
Double stranded RNAs were prepared using MEGA script kit (Ambion). Primers used to generate dsRNAs are described in Supplementary material. 1.2 million cells were plated on 6 well plate and treated with 15µg dsRNA probe in serum free medium.
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Two hours after probe treatment, complete medium was added to the wells and cells were cultured for 2 days before being transfected.
For mRNA quantification total RNA was extracted using TRI Reagent (Sigma)
or RNeasy Mini Kit (Qiagen) following manufacturer's instruction. 1.5µg total RNA was reverse-transcribed by using a random decamer primer (RETROscript kit, Ambion). Quantitative real-time PCR was performed using the SYBR Green Master
Mix method (Sigma) with a Bio-Rad MyiQ system. Full details are in Supplementary Information.
Immunoblotting and immunoprecipitation
Standard protocols were used for Western blotting. 
Cell imaging
Cells were plated on imaging dishes and treated as indicated. For mitochondrial morphology analysis; live cells were incubated with 200µM rhodamine 123 and imaged live in growing medium. Quantification of mitochondria length was performed by using ImageJ software as previously described (45) . For transfected cells;
following treatment, cells were fixed with paraformaldehyde and prepared by standard protocols for immunocytochemistry: Hoechst (2µg/ml), phalloidin AlexaFluor488 (2units), anti-Complex Vα (1:1000). All images were acquired on a DeltaVision DV microscope using standard epifluorescence. Unless stated images were deconvolved after acquisition to improve image clarity and sharpness.
Drosophila stocks and procedures
Drosophila were raised under standard conditions at 25 o C. park 25 and PINK1
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mutants and UAS-parkin have been described before (46), (7). w 1118 and da-GAL4 
